ADVERTISEMENT
Ebola Vaccine Approved for Use in Europe
Ebola Vaccine Approved for Use in Europe
Merck’s Ervebo gets its first regulatory greenlight. A decision from the US Food and Drug Administration is expected in the next few months.
Ebola Vaccine Approved for Use in Europe
Ebola Vaccine Approved for Use in Europe

Merck’s Ervebo gets its first regulatory greenlight. A decision from the US Food and Drug Administration is expected in the next few months.

Merck’s Ervebo gets its first regulatory greenlight. A decision from the US Food and Drug Administration is expected in the next few months.

approvals, disease & medicine

oligomannate alzheimer's disease neurodegeneration microbiome seaweed drug approval china
China Approves Alzheimer’s Treatment that Targets the Microbiome
Kerry Grens | Nov 5, 2019 | 2 min read
Oligomannate, derived from a compound in seaweed, suppresses neural inflammation caused by gut bacteria in mice.
First New Tuberculosis Drug Approved in 50 Years
Jef Akst | Aug 15, 2019 | 2 min read
The US Food and Drug Administration green lights a therapy for an extreme form of multidrug resistant TB.
The Superpowers of Genetically Modified Pigs
Kerry Grens | Aug 1, 2018 | 4 min read
Scientists have engineered swine that pollute less, fend off disease, and produce more meat, but you won’t find them outside experimental farms . . . yet.
Questions Raised About “Breakthrough” Therapies’ Clinical Support
Catherine Offord | Jul 17, 2018 | 2 min read
Compared to other drugs, therapeutics given breakthrough status receive FDA approval on the basis of weaker trial evidence, a study finds.
Genetic Test Could Replace Pap Smear
Kerry Grens | Apr 25, 2014 | 2 min read
The US Food and Drug Administration approves a cervical test for human papillomavirus to be used as a primary cancer screening tool.
ADVERTISEMENT